BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Reddy SP, Lad T, Mullane M, Rosen F, Carroll R, Marks JE. Radiotherapy alone compared with radiotherapy and chemotherapy in patients with squamous cell carcinoma of the esophagus. Am J Clin Oncol. 1995;18:376-381. [PMID: 7572750 DOI: 10.1097/00000421-199510000-00002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
Number Citing Articles
1 Fiore FD, Lecleire S, Rigal O, Galais MP, Soussan EB, David I, Paillot B, Jacob JH, Michel P. Predictive factors of survival in patients treated with definitive chemoradiotherapy for squamous cell esophageal carcinoma. World J Gastroenterol 2006; 12(26): 4185-4190 [PMID: 16830371 DOI: 10.3748/wjg.v12.i26.4185] [Cited by in CrossRef: 48] [Cited by in F6Publishing: 50] [Article Influence: 3.0] [Reference Citation Analysis]
2 Di Fiore F, Lecleire S, Galais M, Rigal O, Vié B, David I, Hamidou H, Paillot B, Jacob J, Michel P. Impact of radiation schedule and chemotherapy duration in definitive chemoradiotherapy regimen for esophageal cancer. Gastroentérologie Clinique et Biologique 2006;30:845-51. [DOI: 10.1016/s0399-8320(06)73331-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
3 Burmeister BH, Walpole ET, Burmeister EA, Thomas J, Thomson DB, Harvey JA, Smithers BM, Gotley DC. Feasibility of chemoradiation therapy with protracted infusion of5-fluorouracil for esophageal cancer patients not suitable for cisplatin. Int J Clin Oncol 2005;10:256-61. [DOI: 10.1007/s10147-005-0506-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
4 Geh J. The use of chemoradiotherapy in oesophageal cancer. European Journal of Cancer 2002;38:300-13. [DOI: 10.1016/s0959-8049(01)00353-7] [Cited by in Crossref: 52] [Cited by in F6Publishing: 5] [Article Influence: 2.6] [Reference Citation Analysis]